It can be concluded (under the specific experimental procedures em? ployed) that:- 1) HCG labelled with 1 – 2 atoms of radioactive iodine did not differ sig? nificantly from the unlabelled hormone; 2) The ovary alone exhibited a capacity to affix specifically HCG; 3) The amount of radioactive material in the ovary was directly proport? ional to the quantity of labelled HCG injected; 4) When the HCG present in the circulation is bound to an antiserum to HCG, the antigen-antibody complex is not concentrated by the ovary; 5) Circulating labelled HCG decreased to 50% within 30 minutes following a single intravenous injection; 6) There are four different phases of ovarian uptake of HCG, namely:? the first phase, when there is only an inflow from the circulation and stor? age mainly in the follicular envelopes; the second phase, when there is a greater inflow than outflow; the third phase, when the inflow is equal to the outflow; and the fourth period, when the outflow is bigger than the in? flow. REFERENCES 1. Lunenfeld, B. and Eshkol, A. Vitamins and Hormones (1967) 25:165 2. Eshkol, A. In: Recent Research on Gonadotropbio Hormones, eds. E. T. Bell andJ. A. Loraine, Edinburgh, Livingstone (1967), p. 202. 3. Eshkol, A. and Lunenfeld, B. Proc. Tel-Hashomer Hosp. (1967) 6:4. ACKNOWLEOOMEN’IS This work was supported in part by a grant from the Population Council, N. Y. , U. S. A. andbyGrantNo.
Medicine
[PDF] Pharmacology of Hormonal Polypeptides and Proteins: Proceedings of an International Symposium on the Pharmacology of Hormonal Polypeptides, held in Milan, Italy, September 14?16, 1967 Iphigenia Photaki (auth.), Nathan Back, Luciano Martini, Rodolfo Paoletti (eds.)
$9.99
Reviews
There are no reviews yet.